在该药上市后期间，已报道发生其他包括以硬结、蜂窝织炎、血肿、脓肿、无菌脓肿以及坏死为指征的注射部位反应事件。
In the postmarketing period, additional cases of injection site reaction with features including induration, cellulitis, hematoma, abscess, sterile abscess, and necrosis, have been reported.
目的探讨药食两用中药复方治疗绝经期综合征的作用机理。
Objective:To explore the therapeutic mechanism of edible Chinese herbal prescription on menopausal syndrome.
因此该药的服用常常没有明确指征或者没有明确该药是否有益于病人。
So, they are given often without having a clear indication or without making sure the patient is benefiting from the medication.
目的：探索药食两用中药复方治疗妇女更年期综合征的机理并为其提供实验依据。
Objective: to explore the principles of treatment of menopausal syndrome with edible Chinese herbal compound and to provide experimental foundation for this treatment.
这些始发症状可与其他的心脏和非心脏原因引起的疾病症状相叠加，包括可由抗精神病药物引起的抗精神病药恶性综合征。
These initial symptoms can overlap considerably with those of other cardiac and non-cardiac conditions, including neuroleptic malignant syndrome (NMS), which may itself be caused by antipsychotics.
结论：小剂量抗抑郁药是治疗难治性结肠易激综合征的安全和有效的药物。
Conclusion: Subclincal dosage of antidepressant is an effective and safe drug for treatment of refractory IBS.
自从1960年首次报道抗精神病药恶性综合征（NMS）后，大量的临床案例已使人们对于NMS的发病机制、临床表现和治疗有了较深的了解。
Since the initial report of neuroleptic malignant syndrome (NMS) in 1960, lots of clinical data have been accumulated on the pathogenesis, manifestations and treatment of NMS.
结论每一个低分子肝素产品间都存在着明显的差异，具有不同的特点，临床使用中应按指征个体化给药。
CONCLUSION Every low molecule heparin product has its own feature, and they should be used individualized in clinic.
目的：探讨抗癫痫药高敏综合征(AHS)的临床特点、诊断、发病机理及治疗。
Objective: To discuss the clinical features, diagnosis, pathogenesis and treatment of antiepileptic drug hypersensitivity syndrome (AHS).
本实用新型 的技术方案是：包括药瓶、给药管、流控开关和喷头，其特 征是在药瓶上设有气泵。
The instrument comprises a medicine bottle, a medicine delivery pipe, a fluid control switch and a spray head and characterized in that the medicine bottle is provided with an air pump.
我们研究了硼替佐米单药在骨髓增生异常综合征中应用的有效性和安全性。
We performed a study on efficacy and safety of bortezomib as a single agent in patients with myelodysplastic syndromes (MDS).
我们研究了硼替佐米单药在骨髓增生异常综合征中应用的有效性和安全性。
We performed a study on efficacy and safety of bortezomib as a single agent in patients with myelodysplastic syndromes (MDS).
应用推荐